Methicillin-resistant Staphylococcus Aureus Clinical Trial
Official title:
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
NCT number | NCT03886623 |
Other study ID # | 2011H0015 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2011 |
Est. completion date | December 2013 |
Verified date | March 2019 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to see if a 4 day oral care program in patients who have been on
a breathing machine results in better oral health, reduces the amount of certain bacteria in
the mouth and reduces infection while in the hospital.
The plan is to test the specific hypotheses that a standardized oral care protocol:
1. Results in improved oral health compared to standard care,
2. Reduces the rate of Staphylococcus aureus / methicillin resistant Staphylococcus aureus,
and
3. Reduces the risk of healthcare-associated infections.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 years or older - Has required mechanical ventilation for at least 48 hours - Meets ventilator liberation criteria (PEEP = 8 and FiO2 = 50%) - Minimum of 3 teeth - Either the subject or their Legally Authorized Representative is capable of reading, understanding and providing written informed consent. Exclusion Criteria: - Non-English speaking - Allergy to products/components of the oral care protocol - Oral or maxillofacial surgery, or oral/facial trauma in last three months - INR > 3.5 or platelet count < 20,000 - Planned hospital discharge within 48 hours - Current diagnosis of mucositis, or undergoing chemotherapy or radiation therapy - Presence of Tracheostomy - Family or physician not in favor of continued medical treatment. - Unable to give informed consent, and/or lack of availability of an authorized representative who can provide consent |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in prevalence of Methicillin-sensitive Staphylococcus aureus (MSSA) in post mechanically ventilated patients as assessed by Oral cultures (Swabs) | The overall purpose of this project is to develop an evidence-based oral care protocol for acutely ill hospitalized patients and determine the impact of this protocol on health outcomes in recently extubated patients. The aim is to assess the impact of an oral care protocol on the following rate of oral colonization with Methicillin-sensitive Staphylococcus aureus (MSSA) | Day 1 and 4 days post-extubation | |
Primary | Change in prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) in post mechanically ventilated patients as assessed by Oral cultures (Swabs) | The overall purpose of this project is to develop an evidence-based oral care protocol for acutely ill hospitalized patients and determine the impact of this protocol on health outcomes in recently extubated patients. The aim is to assess the impact of an oral care protocol on the following rate of MRSA, | Day 1 and 4 days post-extubation | |
Secondary | Determine infection rate of healthcare acquired infections (MSSA and MRSA) in post mechanically ventilated patients receiving oral care using nasal cultures (Swabs) | Obtain Data on the incidence of new MSSA and MRSA infections in the post-mechanically, ventilated post-ICU patient using nasal cultures (Swabs) | 4 days | |
Secondary | Identify change in patient satisfaction in post mechanically ventilated patients who receive oral care using a Patient satisfaction survey/interview. | Assess whether there is an increase in patient satisfaction in those receiving the intervention by using Patient satisfaction survey/interview. | 4 days post extubation | |
Secondary | Identify change in patient quality of life in post mechanically ventilated patients who receive oral care using the Edmonton Symptom Assessment System quality of life assessment tool. | Measure change in patient quality of life as reported using the Edmonton Symptom Assessment System quality of life assessment tool of 0 to 10 scale, where 0 represents no symptom and 10 represents the worst possible severity. | 4 days post extubation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05529173 -
Povidone-Iodine for Nasal Decolonization
|
Phase 4 | |
Completed |
NCT00980980 -
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
|
N/A | |
Recruiting |
NCT03412500 -
Vancomycin Dosage Adjustment for MRSA Infections
|
Phase 4 | |
Recruiting |
NCT02566928 -
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
|
Phase 4 | |
Terminated |
NCT01196169 -
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT00996112 -
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
|
N/A | |
Not yet recruiting |
NCT00773799 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
|
N/A | |
Not yet recruiting |
NCT00773864 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
|
N/A | |
Completed |
NCT01350479 -
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
|
N/A | |
Recruiting |
NCT03637400 -
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
|
Phase 2 | |
Completed |
NCT01200654 -
Population Pharmacokinetics of Linezolid
|
Phase 4 | |
Withdrawn |
NCT00856089 -
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
|
Phase 4 | |
Recruiting |
NCT04171817 -
Animal-Assisted Visitation Program Chlorhexidine Trial
|
Phase 4 | |
Completed |
NCT00324922 -
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
|
Phase 3 | |
Completed |
NCT02814916 -
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
|
Phase 3 | |
Withdrawn |
NCT00713674 -
Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
|
N/A | |
Not yet recruiting |
NCT05632315 -
PMT for MDRO Decolonization
|
Phase 2 | |
Not yet recruiting |
NCT01356472 -
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
|
Phase 4 | |
Completed |
NCT01138462 -
Control of MRSA in Nursing Homes: Decolonization vs Standard Precautions
|
N/A | |
Completed |
NCT01141101 -
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
|
N/A |